Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Chemotherapy-induced steatohepatitis in colorectal cancer patients.

Gentilucci UV, Santini D, Vincenzi B, Fiori E, Picardi A, Tonini G.

J Clin Oncol. 2006 Dec 1;24(34):5467; author reply 5467-8. No abstract available.

PMID:
17135651
2.

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK.

J Clin Oncol. 2006 May 1;24(13):2065-72.

PMID:
16648507
3.

[Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].

Kudo D, Tsutsumi S, Akasaka H, Jin H, Ohashi T, Muroya T, Hasebe T, Sakamoto Y, Ishido K, Koyama M, Toyoki Y, Murata A, Narumi S, Kijima H, Hakamada K.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2025-7. Japanese.

PMID:
20037312
4.

[Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)].

Tannapfel A, Reinacher-Schick A, Flott-Rahmel B.

Pathologe. 2011 Jul;32(4):330-5. doi: 10.1007/s00292-011-1434-2. Review. German.

PMID:
21681471
5.

Impact of locoregional approaches to liver metastases in patients with colorectal cancer.

Danesi R, Paolo AD.

Clin Colorectal Cancer. 2003 May;3(1):45-6. No abstract available.

PMID:
12777191
6.

Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis.

Bower M, Wunderlich C, Brown R, Scoggins CR, McMasters KM, Martin RC.

Am J Surg. 2013 Jun;205(6):685-90. doi: 10.1016/j.amjsurg.2012.07.034. Epub 2013 Feb 4.

PMID:
23388422
7.

[Radiofrequency ablation of colorectal liver metastases].

Vyslouzil K, Klementa I, Starý L, Zboril P, Skalický P, Dlouhý M, Cwiertka K, Duda M.

Zentralbl Chir. 2009 Apr;134(2):145-8. doi: 10.1055/s-2008-1076874. Epub 2009 Apr 20. German.

PMID:
19382045
8.

Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.

Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T.

Eur J Surg Oncol. 2008 Nov;34(11):1231-6. doi: 10.1016/j.ejso.2008.01.001. Epub 2008 Feb 12.

PMID:
18272318
9.

Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.

Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M.

Ann Surg Oncol. 2007 Mar;14(3):1151-60. Epub 2006 Dec 31.

PMID:
17195913
10.
11.

Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.

Nuzzo G, Giuliante F, Ardito F, Vellone M, Pozzo C, Cassano A, Giovannini I, Barone C.

J Gastrointest Surg. 2007 Mar;11(3):318-24.

PMID:
17458605
12.

Extended resections of liver metastases from colorectal cancer.

Jonas S, Thelen A, Benckert C, Spinelli A, Sammain S, Neumann U, Rudolph B, Neuhaus P.

World J Surg. 2007 Mar;31(3):511-21.

PMID:
17308854
13.

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D.

Ann Surg. 2008 Jan;247(1):118-24.

PMID:
18156931
14.

Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.

Mandalà M, Mosconi S, Quadri A, Milesi L, Labianca R.

Expert Rev Anticancer Ther. 2007 Jun;7(6):887-97. Review.

PMID:
17555399
15.

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.

Schulze T, Kemmner W, Weitz J, Wernecke KD, Schirrmacher V, Schlag PM.

Cancer Immunol Immunother. 2009 Jan;58(1):61-9. doi: 10.1007/s00262-008-0526-1. Epub 2008 May 17.

PMID:
18488223
16.

Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.

Dizon DS, Schwartz J, Kemeny N.

Surg Oncol Clin N Am. 2008 Oct;17(4):759-71, viii. doi: 10.1016/j.soc.2008.04.009. Review.

PMID:
18722916
17.

Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?

Abdalla EK, Vauthey JN.

Dig Surg. 2008;25(6):421-9. doi: 10.1159/000184733. Epub 2009 Feb 12. Review.

PMID:
19212114
18.

Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D.

J Clin Oncol. 2008 Aug 1;26(22):3672-80. doi: 10.1200/JCO.2007.15.7297.

PMID:
18669451
19.

A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.

Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, Sato A, Moriya Y; Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2009 Jun;39(6):406-9. doi: 10.1093/jjco/hyp035. Epub 2009 Apr 23.

PMID:
19389795
20.

[Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer].

Heinemann V, Löhe F.

MMW Fortschr Med. 2009 Jan 29;151(5):35-7. German. No abstract available.

PMID:
19391410

Supplemental Content

Support Center